Shenzhen, Guangdong, China Photon Fund appeared to be the VC, which was created in 2015. The main office of represented VC is situated in the Shenzhen. The venture was found in Asia in China.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Photon Fund, startups are often financed by ZTEVC, Kaitai Capital, KTB Ventures. The meaningful sponsors for the fund in investment in the same round are UPC Renewables, Legend Capital, KTB Ventures. In the next rounds fund is usually obtained by Vinno Capital.
Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The top activity for fund was in 2018. The usual things for fund are deals in the range of 10 - 50 millions dollars.
The current fund was established by David Wang, Qing Zhu. Besides them, we counted 2 critical employees of this fund in our database.
Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline CARsgen Therapeutics, Nelumbo, Hongliyu Cinema We can highlight the next thriving fund investment areas, such as Hardware, Medical. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - China.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Asia Pacific Land | China, Hong Kong, Hong Kong Island |
| Canadian Pacific Railway | Canada, Manitoba, Winnipeg |
| Conservation International Ventures | Arlington, United States, Virginia |
| Danen Capital | China, Guangdong, Shenzhen |
| Foxconn | - |
| Guangying Touzi | China, Hangzhou, Zhejiang |
| Gunsynd | England, London, United Kingdom |
| Hsin Investments | - |
| Indigram Labs | Delhi, India, New Delhi |
| Info Edge ventures | India, Noida, Uttar Pradesh |
| MicroVision | Redmond, United States, Washington |
| Mogao Venture Capital | China, Guangdong, Shenzhen |
| Optus | Australia, New South Wales, Sydney |
| Perfect World Capital | District of Columbia, United States, Washington |
| Pharmagest | France, Grand Est, Lorraine |
| Pinetree Capital | Canada, Ontario, Toronto |
| Silo Holdings | - |
| Tokalon Ventures | New York, New York, United States |
| Whitebox Advisors | Minneapolis, Minnesota, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Bichen Pharmaceutical | $30M | 04 Jan 2022 | Shanghai, Shanghai, China | ||
Amplicore | $4M | 25 Mar 2021 | Illinois, United States | ||
Newomics | $7M | 01 Dec 2020 | Berkeley, California, United States | ||
Cardea Bio | $7M | 17 Sep 2020 | San Diego, California, United States | ||
Nelumbo | $14M | 16 Apr 2020 | California, United States | ||
Valitor | $2M | 20 Sep 2018 | Berkeley, California, United States | ||
Newomics | $3M | 09 Aug 2018 | Berkeley, California, United States | ||
Nelumbo | $5M | 27 Jul 2018 | California, United States | ||
| $60M | 02 Mar 2018 | Shanghai, China |
– Amplicore from Cincinnati develops minimally invasive therapeutic solutions for musculoskeletal diseases.
– The company closed its $4m seed round of funding.
– The round was led by Photon Fund, with participation from Industrial Technology Investment Corporation, Berkeley Catalyst Fund, and SVE Capital.
– The new investment will be used to complete the preclinical development of the company’s two leading products, AM3101 and AM1101, and position itself for the next round of financing.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Bichen Pharmaceutical | $30M | 04 Jan 2022 | Shanghai, Shanghai, China | ||
Amplicore | $4M | 25 Mar 2021 | Illinois, United States | ||
Newomics | $7M | 01 Dec 2020 | Berkeley, California, United States | ||
Cardea Bio | $7M | 17 Sep 2020 | San Diego, California, United States | ||
Nelumbo | $14M | 16 Apr 2020 | California, United States | ||
Valitor | $2M | 20 Sep 2018 | Berkeley, California, United States | ||
Newomics | $3M | 09 Aug 2018 | Berkeley, California, United States | ||
Nelumbo | $5M | 27 Jul 2018 | California, United States | ||
| $60M | 02 Mar 2018 | Shanghai, China |
